Your browser doesn't support javascript.
loading
Primary tumour category, site of metastasis, and baseline serum S100B and LDH are independent prognostic factors for survival in metastatic melanoma patients treated with anti-PD-1.
Janka, Eszter Anna; Ványai, Beatrix; Szabó, Imre Lorinc; Toka-Farkas, Tünde; Várvölgyi, Tünde; Kapitány, Anikó; Szegedi, Andrea; Emri, Gabriella.
Afiliação
  • Janka EA; Department of Dermatology, MTA Centre of Excellence, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Ványai B; ELKH-DE Allergology Research Group, Debrecen, Hungary.
  • Szabó IL; Department of Dermatology, MTA Centre of Excellence, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Toka-Farkas T; Doctoral School of Health Sciences, University of Debrecen, Debrecen, Hungary.
  • Várvölgyi T; Department of Dermatology, MTA Centre of Excellence, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Kapitány A; Department of Dermatology, MTA Centre of Excellence, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Szegedi A; Department of Dermatology, MTA Centre of Excellence, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Emri G; Department of Dermatology, MTA Centre of Excellence, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Front Oncol ; 13: 1237643, 2023.
Article em En | MEDLINE | ID: mdl-37664072

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article